Drug intelligence / Profile preview

whey-protein microgel

Development stage: Unknown
Lead developer: Nestlé
Modality: Recombinant Proteins and Enzymes
Administration: Oral

Overview

Whey protein microgel (WPM) is a nutraceutical product developed by Nestlé, formulated using proprietary micelle technology to create a stable, ultra-concentrated whey protein isolate beverage. Designed as a pre-meal drink, it functions as a metabolic modulator by stimulating the endogenous secretion of glucagon-like peptide 1 (GLP-1) and insulin, while also slowing gastric emptying. Clinical studies in individuals with type 2 diabetes and overweight or obesity have demonstrated its efficacy in reducing postprandial glucose levels and curbing appetite. The product is marketed in the United States under the BOOST brand.

Brand names: BOOST
Other names: Whey protein microgelWPMultra-concentrated whey protein isolate

Targets

GLP1R (GLP-1R)INSR (Insulin receptor)

Beyond the preview

Go deeper on whey-protein microgel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on whey-protein microgel.

Explore the full profile